Bosch, J, Eikelboom, J W, Connolly, S J, Bruns, N C, Lanius, V, Yuan, F, Misselwitz, F, Chen, E, Diaz, R, Alings, M, Lonn, E M, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Bhatt, D L, Branch, K R H, Probstfield, J L, Liang, Y, Liu, L, Zhu, J, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Fox, K A A, Kakkar, A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, K, Keltai, M, Ryden, L, Dagenais, G R, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Ha, J-W, Tonkin, A M, Varigos, J D, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Aboyans, V, Metsarinne, K P, Anand, S S, Hart, R G, Lamy, A, Moayyedi, P, Leong, D P, Sharma, M & Yusuf, S 2017, ' Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial ', Canadian journal of cardiology, vol. 33, no. 8, pp. 1027-1035 . https://doi.org/10.1016/j.cjca.2017.06.001 Bosch, J, Eikelboom, J W, Connolly, S J, Bruns, N C, Lanius, V, Yuan, F, Misselwitz, F, Chen, E, Diaz, R, Alings, M, Lonn, E M, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Bhatt, D L, Branch, K R H, Probstfield, J L, Liang, Y, Liu, L, Zhu, J, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Fox, K A A, Kakkar, A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, K, Keltai, M, Ryden, L, Dagenais, G R, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J H, Ha, J W, Tonkin, A M, Varigos, J D, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Aboyans, V, Metsarinne, K P, Anand, S S, Hart, R G, Lamy, A, Moayyedi, P, Leong, D P, Sharma, M & Yusuf, S 2017, ' Rationale, design and baseline characteristics of participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial ', Canadian Journal of Cardiology, vol. 33, no. 8, pp. 1027-1035 . https://doi.org/10.1016/j.cjca.2017.06.001
Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 BASE-Bielefeld Academic Search Engine Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3
Moayyedi, P, Eikelboom, J W, Bosch, J, Connolly, S J, Dyal, L, Shestakovska, O, Leong, D, Anand, S S, Störk, S, Branch, K R H, Bhatt, D L, Verhamme, P B, O'Donnell, M, Maggioni, A P, Lonn, E M, Piegas, L S, Ertl, G, Keltai, M, Bruns, N C, Muehlhofer, E, Dagenais, G R, Kim, J-H, Hori, M, Steg, P G, Hart, R G, Diaz, R, Alings, M, Widimsky, P, Avezum, A, Probstfield, J, Zhu, J, Liang, Y, Lopez-Jaramillo, P, Kakkar, A K, Parkhomenko, A N, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Vinereanu, D, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Metsarinne, K P, Fox, K A A, Yusuf, S & COMPASS Investigators 2019, ' Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin ', Gastroenterology, vol. 157, no. 3, pp. 682-691.e2 . https://doi.org/10.1053/j.gastro.2019.05.056